M. Kulyk & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $706K | Sell |
3,802
-232
| -6% | -$43.1K | 0.15% | 62 |
|
|
2025
Q1 | $845K | Buy |
4,034
+30
| +0.7% | +$6.29K | 0.19% | 58 |
|
|
2024
Q4 | $712K | Sell |
4,004
-852
| -18% | -$151K | 0.15% | 63 |
|
|
2024
Q3 | $959K | Buy |
4,856
+127
| +3% | +$25.1K | 0.19% | 58 |
|
|
2024
Q2 | $811K | Hold |
4,729
| – | – | 0.19% | 58 |
|
|
2024
Q1 | $861K | Sell |
4,729
-125
| -3% | -$22.8K | 0.2% | 57 |
|
|
2023
Q4 | $752K | Hold |
4,854
| – | – | 0.18% | 61 |
|
|
2023
Q3 | $724K | Sell |
4,854
-212
| -4% | -$31.6K | 0.2% | 58 |
|
|
2023
Q2 | $683K | Sell |
5,066
-37
| -0.7% | -$4.99K | 0.19% | 62 |
|
|
2023
Q1 | $813K | Sell |
5,103
-44
| -0.9% | -$7.01K | 0.25% | 59 |
|
|
2022
Q4 | $832K | Buy |
5,147
+75
| +1% | +$12.1K | 0.28% | 60 |
|
|
2022
Q3 | $681K | Hold |
5,072
| – | – | 0.24% | 61 |
|
|
2022
Q2 | $777K | Sell |
5,072
-442
| -8% | -$67.7K | 0.24% | 54 |
|
|
2022
Q1 | $894K | Buy |
5,514
+295
| +6% | +$47.8K | 0.24% | 54 |
|
|
2021
Q4 | $707K | Buy |
5,219
+2,834
| +119% | +$384K | 0.18% | 54 |
|
|
2021
Q3 | $257K | Buy |
2,385
+150
| +7% | +$16.2K | 0.08% | 64 |
|
|
2021
Q2 | $252K | Sell |
2,235
-10
| -0.4% | -$1.13K | 0.09% | 59 |
|
|
2021
Q1 | $243K | Buy |
+2,245
| New | +$243K | 0.09% | 64 |
|